You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dolutegravir

Showing 1 - 25 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gut Microbiota, PGx and INSTIs Response

Recruiting
  • HIV Infections
  • Brussels, Belgium
    Cliniques universitaires Saint-Luc
Jan 16, 2023

Metabolic Effects, Weight Gain, HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Tenofovir

Not yet recruiting
  • Metabolic Effects
  • +3 more
  • Tenofovir alafenamide
  • Dolutegravir
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

HIV-1-infection Trial in Butha-Buthe (Dolutegravir)

Active, not recruiting
  • HIV-1-infection
  • Dolutegravir
  • Butha-Buthe, Lesotho
  • +1 more
Oct 23, 2022

Hiv Trial in Cape Town (Dolutegravir)

Recruiting
  • Hiv
  • Dolutegravir
  • Cape Town, Western Cape, South Africa
    Tygerberg Hospital
Oct 18, 2022

Tuberculosis, HIV Trial (Dolutegravir, 3HP)

Not yet recruiting
  • Tuberculosis
  • HIV
  • (no location specified)
Dec 9, 2022

Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)

Completed
  • Malaria
  • Belfast, Northern Ireland, United Kingdom
    Novartis Investigative Site
Nov 2, 2022

HIV-1-infection, Pregnancy Related Trial in Cape Town, Kampala (Dolutegravir, Standard of Care (EFV + 2 NRTI backbone))

Active, not recruiting
  • HIV-1-infection
  • Pregnancy Related
  • Dolutegravir
  • Standard of Care (EFV + 2 NRTI backbone)
  • Cape Town, Western Cape, South Africa
  • +1 more
Aug 8, 2022

HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

Not yet recruiting
  • HIV
  • HIV Infections
  • Dolutegravir
  • +4 more
  • (no location specified)
Aug 4, 2023

Human Immunodeficiency Virus, Contraception, ART Trial in Gaborone (Dolutegravir, Levonorgestrel implant, Depo

Recruiting
  • Human Immunodeficiency Virus
  • +2 more
  • Dolutegravir
  • +2 more
  • Gaborone, Botswana
    Princess Marina Hospital
Mar 1, 2022

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Dolutegravir
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

HIV Trial in Cape Town (Doravirine, Dolutegravir)

Not yet recruiting
  • HIV
  • Cape Town, South Africa
    Desmond Tutu Health Foundation
Nov 18, 2022

HIV Trial in Worldwide (NRTIs, Dolutegravir, Darunavir)

Active, not recruiting
  • HIV Infections
  • Buenos Aires, Ciudad De Buenos Aires, Argentina
  • +27 more
Nov 27, 2022

Antiretroviral and Related Drugs in Lactating Women and

Not yet recruiting
  • Lactating Women on Select DOI
  • +2 more
  • Dolutegravir
  • +3 more
  • Botswana, Gaborone, South Africa
  • +3 more
Jan 19, 2023

HIV-1 Infection Trial in All The Regions Of The Country (40 Centers) (Dolutegravir, Darunavir-cobicistat,

Completed
  • HIV-1 Infection
  • Dolutegravir
  • +2 more
  • All The Regions Of The Country (40 Centers), France
    (unnamed)
Jan 3, 2022

Effect on HIV Medications on EPC Cells

Completed
  • AIDS
  • Washington, District of Columbia
    The GW Medical Faculty Associates
Mar 21, 2022

HIV-1-infection Trial in London (Dolutegravir)

Not yet recruiting
  • HIV-1-infection
  • Dolutegravir
  • London, United Kingdom
    Chelsea & Westminster Hospital NHS Foundation Trust
Jun 23, 2021

HIV-1-infection Trial in London (Doravirine, Dolutegravir, Triple cART regimen)

Not yet recruiting
  • HIV-1-infection
  • London, United Kingdom
    Chelsea & Westminster Hospital NHS Foundation Trust
Jun 23, 2021

HIV-1-infection, Hepatic Impairment Trial (Dolutegravir)

Withdrawn
  • HIV-1-infection
  • Hepatic Impairment
  • Dolutegravir
  • (no location specified)
Jun 7, 2021

HIV/AIDS Trial in Stanford, Aurora (Darunavir/Cobicistat, Dolutegravir)

Withdrawn
  • HIV/AIDS
  • Stanford, California
  • +1 more
Jul 7, 2021

HIV, Hepatitis C Trial in Aurora (dolutegravir, simeprevir)

Completed
Has Results
  • HIV
  • Hepatitis C
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Feb 23, 2021

HIV-1 Infection Trial in Germany, Netherlands (Atazanavir, Dolutegravir, Lamivudine)

Terminated
  • HIV-1 Infection
  • Bonn, Germany
  • +3 more
Dec 4, 2020

HIV-1-infection Trial in Burkina Faso, Cameroon, Côte D'Ivoire (dolutegravir, atazanavir boosted with ritonavir, tenofovir +

Recruiting
  • HIV-1-infection
  • dolutegravir
  • +3 more
  • Bobo-Dioulasso, Burkina Faso
  • +4 more
Oct 14, 2021

HIV Trial in Worldwide (GSK3640254, Dolutegravir, Lamivudine capsules)

Active, not recruiting
  • HIV Infections
  • Bakersfield, California
  • +75 more
Jul 1, 2022

Tuberculosis, HIV Trial in Lima, Cape Town (Bedaquiline, Delamanid, Dolutegravir)

Completed
Has Results
  • Tuberculosis
  • HIV Infections
  • Lima, Peru
  • +2 more
Jan 20, 2022

Healthy Volunteer Trial in Austin, Hachioji City (S-648414, Placebo, Midazolam)

Completed
Has Results
  • Healthy Volunteer
  • Austin, Texas
  • +1 more
Oct 21, 2021